Dr. Zoubeidi and her BRN2 publications featured in VCHRI Newsletter

Date Posted: 
2016-11-29

Dr. Amina Zoubeidi is the focus of a Nov. 25 article in the Vancouver Coastal Health Research Institute newsletter.  Read the full article here (opens in new window).

As reported on October 30 this year, a study lead by Dr. Zoubeidi with a team from the Vancouver Prostate Centre and collaborators at Weill Cornell Medicine was published online on October 26, in AACR's journal Cancer Discovery. This publication, titled "The Master Neural Transcription Factor BRN2 is an Androgen Receptor Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer", reports a new potential target for treating/preventing neuroendocrine differentiation in prostate tumours.  This discovery was also published as a Research Highlight in Nature Reviews Urology.

 

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Step Up Challenge fundraiser: Feb 19 in Vancouver

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on February 19. Once again, VPC researchers are taking on the challenge to climb 375 flights of stairs; click here to sponsor our team.

BMO Vancouver Marathon, May 7: Prostate Cancer Foundation BC fundraiser

Prostate Cancer Foundation BC has a fundraising page for participants in the BMO Vancouver Marathon on May 7th.  You can make a donation by clicking here, or contact PCF-BC for more information of how to help at prostatebceventsattelus [dot] net.

Employment

Work at the Vancouver Prostate Centre

Monday, January 30, 2017

Dr. Amina Zoubeidi leads identification of gene linked to growth of aggressive neuroendocrine prostate cancer (NEPC)

DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.

Movember